// STATE LEGISLATION TRACKER

Arizona HB 2953: pharmacy board; civil penalties.

⚖️ MIXED for peptide users 👤 LOW user impact 📜 Status: Signed

State: Arizona
Bill: HB 2953
Session: 57th-2nd-regular
Filed: 2026-02-02
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Arizona HB2953 caps certain Arizona State Board of Pharmacy civil penalties at $25,000 in a six-month period and lets the board consider a licensee’s recent history when setting lower penalties. It does not appear to change peptide prescribing, telehealth, naturopathic or NP scope, federal 503A/503B compounding rules, controlled-substance rules, or prescription monitoring access.

Key Points

Arizona pharmacy penalties are capped for certain violations
Compounding pharmacies may face more predictable enforcement costs
No direct change to peptide prescribing or off-label use
No direct expansion or restriction of telehealth access
No change identified for NP or naturopathic scope

What to Watch For

✓

Opportunity Lower penalty exposure may reduce compliance-cost pressure on pharmacies, including compounders.

Note The bill is about Arizona pharmacy board penalties, not peptide legality or prescribing rights.

Concern Board discipline, permit suspension, and revocation still remain available for serious violations.

Where the Bill Stands

The bill has been signed by the Governor and is no longer just pending in the legislature.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws